Cargando…
Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 Is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone
(‒)-Sophoranone (SPN) is a bioactive component of Sophora tonkinensis with various pharmacological activities. This study aims to evaluate its in vitro and in vivo inhibitory potential against the nine major CYP enzymes. Of the nine tested CYPs, it exerted the strongest inhibitory effect on CYP2C9-m...
Autores principales: | Zheng, Yu Fen, Bae, Soo Hyeon, Huang, Zhouchi, Chae, Soon Uk, Jo, Seong Jun, Shim, Hyung Joon, Lee, Chae Bin, Kim, Doyun, Yoo, Hunseung, Bae, Soo Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238241/ https://www.ncbi.nlm.nih.gov/pubmed/32272615 http://dx.doi.org/10.3390/pharmaceutics12040328 |
Ejemplares similares
-
Analytical Method Development of Benzisothiazolinone, a Biocide, Using LC–MS/MS and a Pharmacokinetic Application in Rat Biological Matrices
por: Jo, Seong Jun, et al.
Publicado: (2023) -
Benzisothiazolinone: Pharmacokinetics, Tissue Distribution, and Mass Balance Studies in Rats
por: Jo, Seong Jun, et al.
Publicado: (2023) -
Simultaneous quantification of ticagrelor and its active metabolite, AR-C124910XX, in human plasma by liquid chromatography-tandem mass spectrometry: Applications in steady-state pharmacokinetics in patients
por: Chae, Soon Uk, et al.
Publicado: (2019) -
Clinical Pharmacokinetics of Approved RNA Therapeutics
por: Jo, Seong Jun, et al.
Publicado: (2023) -
The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
por: Lee, Chae Bin, et al.
Publicado: (2021)